InsiderTrades.com logo

ACCD Insider Trading

Insider Ownership Percentage: 8.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $366,281.22

Accolade Insider Trading History Chart

This chart shows the insider buying and selling history at Accolade by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$16ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Accolade Share Price & Price History

Current Price: $7.02
Price Change: +0.30 (1.20%)
As of 04/8/2025 01:00 AM ET

This chart shows the closing price history over time for ACCD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JulAugSepOctNovDecJanFebMarAprMay$7.02Closing price on 05/27/25:

SEC Filings (Institutional Ownership Changes) for Accolade (NASDAQ:ACCD)

84.99% of Accolade stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACCD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$136Mbought$27MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
Accolade logo
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Read More on Accolade

Today's Range

Now: $7.02
Low: $7.02
High: $7.02

50 Day Range

MA: $7.02
Low: $6.98
High: $7.03

52 Week Range

Now: $7.02
Low: $3.08
High: $7.70

Volume

N/A

Average Volume

1,549,914 shs

Market Capitalization

$575.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Who are the company insiders with the largest holdings of Accolade?

Accolade's top insider investors include:
  1. Rajeev Singh (CEO)
  2. Stephen H Barnes (CFO)
  3. Robert N Cavanaugh (President)
  4. Richard Eskew (EVP)
  5. Colin Mchugh (CAO)
Learn More about top insider investors at Accolade.

Who are the major institutional investors of Accolade?

Accolade's top institutional investors include:
  1. Magnetar Financial LLC — 7.01%
  2. Alliancebernstein L.P. — 6.34%
  3. Vanguard Group Inc. — 5.11%
  4. Polar Asset Management Partners Inc. — 2.29%
  5. Alpine Associates Management Inc. — 2.13%
  6. Goldman Sachs Group Inc. — 2.08%
Learn More about top institutional investors of Accolade stock.

Which institutional investors are selling Accolade stock?

Within the last quarter, ACCD stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Cubist Systematic Strategies LLC
  3. AQR Capital Management LLC
  4. Clearline Capital LP
  5. Johnson Financial Group LLC
  6. Tocqueville Asset Management L.P.
  7. Ieq Capital LLC
  8. XTX Topco Ltd
During the last year, company insiders that have sold Accolade company stock include:
  1. Rajeev Singh (CEO)
  2. Stephen H Barnes (CFO)
  3. Robert N Cavanaugh (President)
  4. Richard Eskew (EVP)
  5. Colin Mchugh (CAO)
Learn More investors selling Accolade stock.

Which institutional investors are buying Accolade stock?

During the last quarter, ACCD stock was purchased by institutional investors including:
  1. Magnetar Financial LLC
  2. Alliancebernstein L.P.
  3. Polar Asset Management Partners Inc.
  4. Alpine Associates Management Inc.
  5. Goldman Sachs Group Inc.
  6. ABC Arbitrage SA
  7. Gabelli Funds LLC
  8. GABELLI & Co INVESTMENT ADVISERS INC.